How should severe gastric ulcers be managed?

Management of Severe Gastric Ulcers

For severe gastric ulcers with active bleeding or high-risk stigmata (visible vessel), immediate endoscopic hemostatic therapy with thermocoagulation or sclerosant injection combined with high-dose intravenous PPI therapy is the standard of care, followed by H. pylori testing and eradication if present 1.

Initial Assessment and Risk Stratification

When encountering a severe gastric ulcer, immediately determine if bleeding is present and assess endoscopic stigmata:

• High-risk stigmata requiring intervention: active bleeding or visible vessel in ulcer bed
• Intermediate-risk: adherent clot (controversial whether to treat)
• Low-risk: flat pigmented spot or clean base

Endoscopic Management

For High-Risk Bleeding Ulcers

Endoscopic hemostatic therapy is mandatory 1. The preferred approaches are:

• Thermocoagulation or sclerosant injection (strong recommendation, low-quality evidence) 1
• Through-the-scope clips can be used but have weaker evidence support (conditional recommendation, very low-quality evidence) 1
• Avoid epinephrine injection alone—it provides suboptimal efficacy and must be combined with another method 1

For Adherent Clots

Attempt targeted irrigation to dislodge the clot, then treat the underlying lesion appropriately. The role of endoscopic therapy for adherent clots remains controversial; intensive PPI therapy alone may suffice 1.

Combination Therapy Principle

No single thermal coaptive method is superior to another, but epinephrine monotherapy is inadequate 1. Always combine injection therapy with mechanical or thermal methods.

Pharmacologic Management

Proton Pump Inhibitor Protocol

For ulcers with high-risk stigmata after successful endoscopic therapy, administer IV PPI as a loading dose followed by continuous IV infusion (strong recommendation, moderate-quality evidence) 1. This is superior to no treatment or H2-receptor antagonists.

After the initial 3-day high-dose IV PPI period:

• Switch to twice-daily oral PPIs for 14 days, then once daily (conditional recommendation) 1
• Continue single daily-dose oral PPI for duration dictated by underlying cause 1

What NOT to Use

• H2-receptor antagonists are not recommended for acute ulcer bleeding 1
• Somatostatin and octreotide are not routinely recommended 1

H. Pylori Management

All patients must be tested for H. pylori and receive eradication therapy if positive (strong recommendation) 2. This is critical because:

• Post-treatment H. pylori status independently predicts rebleeding
• Eradication dramatically reduces ulcer recurrence and rebleeding rates

Important caveat: Tests for active infection may show increased false-negatives during acute bleeding. If initial testing is negative, perform confirmatory testing after the acute bleeding episode resolves 2.

Hospitalization and Monitoring

• Patients with high-risk stigmata requiring endoscopic hemostasis should be hospitalized for at least 72 hours 1
• Low-risk patients can be fed within 24 hours and may be discharged after stabilization 1, 2
• Routine second-look endoscopy is not recommended 1
• If rebleeding occurs, a second attempt at endoscopic therapy is generally recommended 1

When Endoscopic Therapy Fails

If endoscopic hemostasis fails:

1. Seek surgical consultation immediately 1
2. Consider percutaneous embolization as an alternative to surgery where available 1

Special Considerations for Gastric Ulcers

Malignancy Exclusion

Unlike duodenal ulcers, gastric ulcers require mandatory biopsy and follow-up endoscopy to exclude malignancy 3. Approximately 8-9% of perforated gastric ulcers harbor underlying malignancy 3.

Risk factors for malignancy include:

• Older age
• Larger ulcer size (>2 cm)
• Non-antral location 4

All gastric ulcers must be re-endoscoped to verify complete healing 5. However, ulcers with macroscopically benign appearance, at least six negative biopsies, and low risk scores may not require routine follow-up 4.

NSAID-Related Ulcers

If NSAIDs are implicated:

• Discontinue NSAIDs if possible 6, 5
• If NSAIDs cannot be stopped, treat with PPIs and consider maintenance therapy with prostaglandins or potent antisecretory drugs 5

Surgical Indications

Surgery is now reserved for complications occurring in 10-20% of cases 7:

Emergency Indications:

• Perforation: Omental patch repair for most cases (91% of perforations) 3; resection for large perforations or suspected malignancy
• Uncontrolled bleeding: After failed endoscopic therapy
• Gastric outlet obstruction

Surgical Approach for Perforation:

• Omental patch repair is effective for almost all perforated gastric ulcers 3
• Resection preferred if ulcer is large or malignancy suspected
• Always obtain biopsies during surgery 3

The mortality rate for perforated gastric ulcers remains significant at approximately 16%, with morbidity exceeding 50% 3. Early diagnosis and immediate intervention are critical for reducing mortality 7.